Times Pharmacy is categorized under Wholesale Pharmaceutical Products in Tampa, FL and active since 2010.
Times Pharmacy was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Olusegun Ayuba at the company’s single location by writing to 2210 East Hillsborough Avenue # 4, Tampa, Florida FL 33610 or by phoning (813) 237-6900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Times Pharmacy |
| Contact Person: | Olusegun Ayuba |
| Address: | 2210 East Hillsborough Avenue # 4, Tampa, Florida 33610 |
| Phone Number: | (813) 237-6900 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 4461100 |
| Share This Business: |
Times Pharmacy was started in 2010 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Olusegun Ayuba for inquiries that concern Times Pharmacy by calling the company number (813) 237-6900, as your correspondence is most welcome. Additionally, the physical location of the single location of Times Pharmacy can be found at the coordinates 27.99619,-82.43345 as well as the street address 2210 East Hillsborough Avenue # 4 in Tampa, Florida 33610.
For its online presence, you may visit Times Pharmacy’s website at and engage with its social media outlets through on Twitter and on Facebook.